4-Thiazolecarboxylicacid, 2-Chloro-, Ethyl Ester

Synthesized at multi-ton scale through esterification of 2-chloro-4-thiazolecarboxylic acid or via direct condensation of ethyl chlorooxalate with thiourea precursors, this heteroaromatic ester enters the agrochemical supply chain predominantly as the electrophilic partner in nucleophilic aromatic substitution cascades that yield 2-aminothiazole-4-carboxylate fungicide cores. In a representative campaign targeting a pyrazole-carboxamide SDHI framework, one equivalent of the ethyl ester is suspended in anhydrous tetrahydrofuran at 0–5°C under a nitrogen blanket, followed by dropwise addition of 1.25 eq of 40% aqueous methylamine over 90 minutes while the reaction mass is maintained below 8°C to suppress THF peroxide formation. HPLC monitoring (C18 column, 0.1% TFA/MeCN gradient, UV 254 nm) confirms full consumption of starting material within 3–4 hours. The crude 2-(methylamino)thiazole-4-carboxylate is hydrolyzed in situ with 3.0 eq of 50% sodium hydroxide in ethanol/water 5:1 at 60°C for 6 hours, acidified to pH 2.5 with concentrated HCl, and the precipitated acid filtered, washed, and vacuum-dried at 45°C to ≤0.5% loss on drying. The isolated intermediate routinely exceeds 98.7% assay by external standard against a reference standard characterized by ¹H NMR (DMSO-d₆, 400 MHz) and 13C NMR. Acylation proceeds via formation of the acid chloride using 1.5 eq thionyl chloride with 0.15 mol% dimethylformamide in toluene at 75–80°C until off-gas evolution ceases, followed by solvent swap to dichloromethane and coupling with a substituted aniline (1.05 eq) in the presence of 1.2 eq triethylamine at –5 to 0°C. The exothermic profile of the acid chloride formation, measured by reaction calorimetry in a 500 mL RC1e system, reveals an adiabatic temperature rise of 35 K, requiring jacket-controlled dosing pumps on production-scale 6,300 L glass-lined reactors. The final SDHI intermediate is crystallized from isopropanol/water and drummed in 25 kg HDPE containers with double PE liners under argon-blanketed storage at 2–8°C. Analytical release includes GC headspace for residual dichloromethane (≤600 ppm, compliant with ECHA Guidance R.16), ICP-MS elemental impurity screen (Class 1 metals ≤1 μg/g each), and w/w assay against a characterized in-house standard using the same USP 〈621〉-aligned HPLC method. The validated process capability indices (Cpk > 1.33 for purity, Cpk > 1.67 for residual solvent) were obtained from 25 consecutive commercial batches, confirming fitness for formulation into suspension concentrates or wettable granules before blending with co-formulants such as surfactant alkoxylates and naphthalene sulfonate dispersants.

Route scouting for a hepatitis C NS5A replication complex inhibitor utilized the chloro-ethyl ester as a divergent scaffold, exploiting the halogen atom’s reactivity under palladium catalysis while keeping the ester function masked to direct downstream orthogonal transformations. A Buchwald–Hartwig amination was executed in a 20 L jacketed vessel charged with 12.3 kg of the thiazole ester, 1.05 eq of tert-butyl 4-aminopiperidine-1-carboxylate, 0.5 mol% Pd₂(dba)₃, 2.0 mol% Xantphos, and 1.4 eq of sodium tert-butoxide in degassed, inhibitor-free tetrahydrofuran. The batch was stirred at 500 rpm with a retreat-curve impeller under a positive nitrogen sweep (0.2 bar gauge) and heated to 63°C internal for 16 hours, achieving 94% conversion as determined by subtraction of relative area percentages from a calibrated UPLC method (sub-2 μm C18, 1.7 mL/min, 0.1% formic acid/MeCN). After filtration through a 0.5 μm sintered metal candle loaded with Celite 545, the filtrate was concentrated to 4 volumes and quenched into 15 volumes of chilled water, and the resulting amorphous solid was subjected to hot filtration at 50°C to purge insoluble palladium black. The product was recrystallized from ethanol/ethyl acetate to achieve a polymorphically consistent white crystalline powder with 99.1% chromatographic purity. The campaign was operated under a split-level quality regime: steps up to and including recrystallization were conducted in non-dedicated, ISO 8-tuned cleanrooms with full segregation of ancillary equipment, while the final micronization and packaging into 500 g amber glass bottles occurred under ISO 7 conditions with continuous particle counting. Because the molecule is destined for phase-2 clinical manufacturing, the conversion process was audited against the ICH Q7 GMP guide for active pharmaceutical ingredients, with specific verification of elemental impurity limits per ICH Q3D (oral bioavailability option 2A: cadmium ≤2 μg/g, lead ≤5 μg/g, arsenic ≤1.5 μg/g, mercury ≤0.3 μg/g). Residual solvent analysis by headspace GC under harmonised pharmacopoeial Pharmeuropa 5.4 conditions targets THF (≤720 ppm), ethanol (≤5,000 ppm), DMF (not detected, reporting threshold 10 ppm), and EtOAc (≤5,000 ppm). Stability under accelerated conditions (40°C/75%RH open dish for 6 months) indicates no significant degradation (<0.3% total impurities growth) when stored in borosilicate containers; exposure to polystyrene or HDPE for > 72 hours leads to extractables leaching and should be prohibited during quarantine.

What Triggers the Need for Ultra-Low Metal Content in Blue Phosphorescent OLED Interlayer Syntheses?

The bidentate N,S-chelating character of the thiazole ring after deschloration renders the ethyl ester a strategic precursor to cyclometalated iridium(III) complexes used as sky-blue emitters in bottom-emission AMOLED stacks. A Suzuki–Miyaura cross-coupling between the chlorothiazole ester and 4-(diphenylamino)phenylboronic acid pinacol ester is conducted in a 50 L oil-heated, double-anchored glass reactor with a reflux condenser rated for 120°C operation. The charge stoichiometry comprises 1.0 eq chlorothiazole ester, 1.1 eq boronate, 1.5 mol% Pd(PPh₃)₄, and 2.5 eq potassium carbonate as a fine powder (325 mesh) in a degassed mixture of 1,4-dioxane and water 4:1 v/v with a total solvent ratio of 10 L/kg substrate. The reactor is inerted through three vacuum/nitrogen breaking cycles before the heating ramp is initiated at 0.8°C/min to a final internal temperature of 88°C, held for 22 hours, with in-process sampling every 4 hours drawn through a 0.2 μm Whatman GD/XP syringe filter directly into chilled, acid-quenched vials to freeze the catalytic cycle. Upon completion, the biphasic mixture is cooled to 40°C and diluted with 2.0 volumes of ethyl acetate, then sequentially washed with 5% aqueous cysteine hydrochloride (3 × 5 volumes) to scavenge soluble palladium species and with 10% brine until the aqueous phase conductivity drops below 50 μS/cm. The organic stream is dried over anhydrous magnesium sulfate (2 wt% relative to product) and passed through a short column of mercaptopropyl-functionalized silica (Pd-TRAP, 100 g per kg of product) before concentration under 60 mbar at 40°C. The crude bis-aryl coupling product is recrystallized three times from chlorobenzene/heptane 1:3 with a final sublimation step in a gradient tube furnace (10⁻⁶ mbar, hot zone 260–270°C, cold finger 15°C) to yield an analytically pure ligand precursor with 99.99% assay by GC-FID area normalization (DB-5HT 30 m × 0.25 mm, 0.10 μm film). ICP-MS measurements on the sublimed material specify sodium ≤0.5 ppm, potassium ≤0.2 ppm, palladium ≤0.05 ppm, iron ≤0.3 ppm, and zinc ≤0.1 ppm, all measured against NIST SRM 3100 series standard solutions. These thresholds are dictated not by chemical instability but by the long-term device physics of OLED operation: residual ionic species drive electromigration that shortens T₉₅ luminance lifetimes by over 40% at a constant current density of 10 mA/cm², as characterized by dark spot growth analysis on encapsulated 2 mm × 2 mm dot arrays. The downstream coordination chemistry with iridium trichloride hydrate in 2-ethoxyethanol/water under nitrogen requires strict control of the ligand/halide bridge cleavage ratio at 2.2:1 molar to avoid the kinetically trapped bis-adduct tris-homoleptic degradation channel that emits below 0.15 cd/A in an unoptimised device stack. No GMP overlay is required, but incoming estate receiving must provide a certificate of compliance to the SEMI C35 photolithography chemical purity guideline as a cross-calibrated benchmark for trace metals, even though the application is outside front-end semiconductor manufacturing.

Heterocyclic Diazo Component Configuration in High-Washfastness Disperse Dyes for PET Textiles

Textile dye formulation utilises the 2-chloro-4-thiazolecarboxylic acid ethyl ester as a latent heterocyclic amine precursor that, after hydrolysis and Curtius-type rearrangement or selective amidine formation, generates a bathochromically shifted diazo component with an extended conjugation pathway relative to aniline-based chromogens. In a typical high-temperature exhaust dyeing process for polyester, the intermediate is first converted into 2-amino-4-thiazolecarboxylic acid ethyl ester via ammonolysis with concentrated ammonium hydroxide in a sealed, stainless-steel autoclave at 105°C and 2.5 bar autogenous pressure, achieving at least 95% conversion when the molar ratio of NH₃ to ester is maintained above 8:1. The amino thiazole is then diazotized with 1.02 eq sodium nitrite in concentrated sulfuric acid/n-propanol mixture at –5 to 0°C, immediately coupled with N,N-diethyl-m-toluidine solubilised in dilute hydrochloric acid, and the resulting monoazo disperse dye is precipitated at pH 4.5, isolated via filter press, and dried in a fluidised bed at 60°C to residual moisture ≤1.0%. The dye exhibits a λ_max of 478–482 nm in DMF with a molar extinction coefficient exceeding 32,000 L mol⁻¹ cm⁻¹, offering an orange-to-red shade on knitted PET substrate at 2.0% owf with a building-up curve that plateaus at 4.5% owf. Light fastness ratings of 6–7 (ISO 105-B02:2014, xenon arc, blue wool scale) and wash fastness of 4–5 on the AATCC TM61-2A test are achievable when the dye is applied in a synergistic combination with a benzotriazole-based UV absorber at 0.3% owf.

Laboratory supply chains distribute the ethyl ester as a pre-weighed, septum-capped research intermediate intended for high-throughput parallel synthesis screens in pharmaceutical and agrochemical discovery units. Packages typically contain 1 g, 5 g, or 25 g of white to off-white crystalline material with a guaranteed purity of ≥97.0% by GC and identity confirmed by FT-IR matched to a curated spectral library and melting point observed at 42–45°C (capillary, uncorrected). The batch-specific certificate of analysis reports a single-point Karl Fischer water content (≤0.3%) and a ¹H quantitative NMR assay against a certified dimethyl terephthalate internal standard to serve as an orthogonal purity check for moisture-free weight calculation. Distribution control complies with the dual-use chemical governance framework of Commission Delegated Regulation (EU) 2023/66, and the safety data sheet segregates exposure scenarios for laboratory-scale handling with a derived no-effect level (DNEL) based on a read-across from structurally related halogenated thiazoles, since a dedicated repeated-dose toxicity study has not been deposited in the ECHA registration dossier for this substance.